FDA Clears First COVID-19 Home Antigen Test

November 10, 2023 by Dan McCue
FDA Clears First COVID-19 Home Antigen Test
(Photo courtesy ACON Laboratories)

WASHINGTON — The Food and Drug Administration has approved the sale of the first over-the-counter antigen test for COVID-19.

The product, ACON Laboratories’ Flowflex COVID-19 Antigen Home Test, originally authorized for emergency use in 2021, is now the second home COVID-19 test to successfully complete a traditional FDA premarket review pathway.

In June the agency granted “market authorization” for the Cue COVID-19 Molecular Test. 

That product is a molecular nucleic acid amplification test that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. 

The FDA’s latest approval, announced Thursday, also marks the first time the test has been approved for use in children under 18. Today’s announcement follows clearance of a molecular home test earlier this year.

Dr. Jeff Shuren, J.D., director of the FDA’s Center for Devices and Radiological Health, said Thursday’s decision was part of an ongoing effort by the agency to help test developers provide consumers with additional options for safe and effective at-home COVID tests.

“The FDA continues to proactively work with test developers that desire to market their products beyond emergency use authorities. This is part of the FDA’s broader effort to advance the development and availability of at-home tests for a variety of medical conditions to expand patient access to testing,” Shuren said in a written statement.

The Flowflex COVID-19 Antigen Home Test is a visually read test cleared for OTC home use for symptomatic individuals within six days of symptom onset. 

The FDA said it can be used by individuals aged 14 years or older to test themselves, or by adults testing individuals aged two years or older.

In a study reviewed by the FDA, the Flowflex COVID-19 Antigen Home Test correctly identified 89.8% of positive and 99.3% of negative samples in individuals with signs and symptoms of upper respiratory infection. 

The agency went on to say that, as with antigen tests authorized for emergency use, the Flowflex test is intended to be used at least twice over three days with at least 48 hours between tests. 

“This means that a symptomatic individual with an initial negative test result should be re-tested once between 48 and 72 hours after the first test using an antigen test for COVID-19 or followed up with a molecular COVID-19 test,” the FDA explained in the release announcing its decision.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue

A+
a-
  • COVID-19
  • FDA
  • Flowflex
  • over-the-counter
  • In The News

    Health

    Voting

    In The News

    December 11, 2023
    by Tom Ramstack
    Trial Begins in Giuliani Defamation Case to See How Much He Will Pay

    WASHINGTON — Jury selection was completed and opening arguments started Monday in a civil trial in Washington, D.C., to determine... Read More

    WASHINGTON — Jury selection was completed and opening arguments started Monday in a civil trial in Washington, D.C., to determine how much money former Trump lawyer and New York City Mayor Rudy Giuliani must pay two Georgia election workers he falsely accused of voter fraud. Their... Read More

    December 11, 2023
    by Dan McCue
    Iowa Dems Set Caucus Candidates on Preference Cards

    DES MOINES, Iowa — The Iowa Democratic Party on Saturday voted to include three names on the 2024 presidential preference... Read More

    DES MOINES, Iowa — The Iowa Democratic Party on Saturday voted to include three names on the 2024 presidential preference cards Iowans will use to cast their votes during the state’s Jan. 15 caucuses. The names that will appear are those of President Joe Biden, Rep.... Read More

    December 10, 2023
    by Dan McCue
    Carter Votes for Cares Act Even as Hyundai Speeds Construction of Georgia EV Plant

    WASHINGTON — It was a matter of preserving consumers’ choice in the face of federal mandates. That’s how Rep. Buddy... Read More

    WASHINGTON — It was a matter of preserving consumers’ choice in the face of federal mandates. That’s how Rep. Buddy Carter, R-Ga., explained his vote last week in favor of the Choice in Automobile Retail Sales Act, even as the Hyundai Motor Group is rushing to... Read More

    December 10, 2023
    by Dan McCue
    BP Completes Tech Upgrade of Indiana Wind Farm

    HOUSTON — Oil and gas giant BP recently fulfilled a major goal of its renewable energy division, completing what it... Read More

    HOUSTON — Oil and gas giant BP recently fulfilled a major goal of its renewable energy division, completing what it calls a “major” technology upgrade at its Fowler Ridge 1 wind farm in northwest Indiana. The upgrade included the installation of two new Vestas turbines expected... Read More

    December 10, 2023
    by Dan McCue
    Hydrogen Fuel Equipment Company Expanding to South Carolina

    LONGVIEW, N.C. — OneH2, a hydrogen fuel equipment manufacturer, is opening a new production facility in Clover, South Carolina. The... Read More

    LONGVIEW, N.C. — OneH2, a hydrogen fuel equipment manufacturer, is opening a new production facility in Clover, South Carolina. The building, which is more than 246,000 square feet, was recently purchased by OneH2 from the Belmont Land and Investment Company LLC. The facility, which is surrounded... Read More

    December 8, 2023
    by Dan McCue
    Appeals Court Largely Upholds Trump DC Gag Order

    WASHINGTON — A federal appeals court panel on Friday largely upheld a gag order imposed on former President Donald Trump... Read More

    WASHINGTON — A federal appeals court panel on Friday largely upheld a gag order imposed on former President Donald Trump in the criminal case accusing him of trying to overturn the results of the 2020 election, but loosened it just enough to allow criticism of the... Read More

    News From The Well
    scroll top